Skip to main content
. Author manuscript; available in PMC: 2021 Aug 15.
Published in final edited form as: Stat Med. 2020 May 10;39(18):2447–2476. doi: 10.1002/sim.8549

TABLE 4.

Huntington’s Disease Application: Results from Examining Individual Observed Confounders;

Single Confounder Inclusion
Δps (Xj) λ(Xj) [SE] B(Xj) [SE]
Age −0.47 0.01 [0.01] 0.01 [0.01]
CAG −0.42 −0.04 [0.01] 0.08 [0.02]
Baseline HD Severity −0.05 −0.41 [0.04] 0.74 [0.03]
Education −0.40 −0.06 [0.01] 0.11 [0.02]
Drug Use −0.46 0.00 [0.00] 0.00 [0.00]
Antidepressant use −0.43 −0.03 [0.01] 0.05 [0.02]
Single Confounder Removal
Δps (Xj) λ(Xj) [SE] B(Xj) [SE]
Age −0.07 −0.02 [0.01] 0.08 [0.03]
CAG −0.08 −0.01 [0.01] 0.04 [0.02]
Baseline HD Severity −0.31 0.22 [0.03] 0.84 [0.04]
Education −0.08 −0.01 [0.01] 0.03 [0.02]
Drug Use −0.09 0.00 [0.00] 0.00 [0.01]
Antidepressant use −0.09 0.00 [0.00] 0.01 [0.01]

SE = standard error